ArticleAnnals of clinical microbiology and antimicrobials2026
Within-host mechanisms of resistance evolution in polymyxin B-resistant Klebsiella pneumoniae without prior exposure.
Article in Annals of clinical microbiology and antimicrobials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPolymyxin B-resistant Klebsiella pneumoniae (PBR-KP) has been emerging as a significant concern. This study investigated the within-host mechanisms of resistance evolution in PBR-KP without prior PB exposure.
methodsSix groups were enrolled [PB-sensitive K. pneumoniae (PBS-KP) evolved into PBR-KP from the same patient], and antimicrobial susceptibility testing was conducted using the microdilution broth method. Whole-genome sequencing was performed to analyze molecular characteristics, and to investigate the resistance mechanisms, gene expression analysis of pmrAB, phoPQ, crrAB, and eptA was performed using RT-qPCR. Fitness costs were assessed through biofilm formation, in vitro growth rate, and virulence analysis.
resultsAll 12 strains belonged to ST11-KL64, except for PB9 and PB10, which were classified as ST11-KL47. Each resistant strain was highly related to its corresponding sensitive strain. The relative expression levels of phoPQ, eptA, and pmrAB were significantly upregulated in most PBR-KP strains. PBR-KP strains exhibited no fitness cost regarding in vitro growth rate and biofilm formation. Notably, the eptA gene was highly expressed in the four PBR-KP strains with enhanced virulence, indicating its association with virulence. Furthermore, PBR-KP strains with enhanced virulence were highly associated with KL64, whereas those without enhanced virulence were linked to KL47, except for PB12, indicating a potential relationship between virulence and serotype.
conclusionsPB resistance can develop in KP strains without prior exposure to the drug, possibly driven by upregulation of phoPQ, pmrAB, and eptA, as supported by validated transcriptomics data. These resistant strains did not exhibit fitness costs related to biofilm formation or growth rate. Enhanced virulence, found in most PBR-KP strains, may be closely associated with eptA overexpression and specific serotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.